Related Experiment Video
Updated: Feb 17, 2026
Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Retinopathy of prematurity - from recognition of risk factors to treatment recommendations
Insights
Retinopathy of prematurity (ROP) is a serious eye condition in premature infants. Early screening and laser therapy are crucial for managing this disorder and preventing vision loss.
Area of Science:
- Ophthalmology
- Neonatology
- Developmental Biology
Background:
- Retinopathy of prematurity (ROP) is a critical retinal vascular disorder affecting premature infants.
- Disturbed retinal vasculature growth in ROP can lead to hypoxia and severe complications like retinal detachment.
- Key risk factors include hyperoxemia, low insulin-like growth factor 1 (IGF-I) levels, and low birth weight for gestational age.
Purpose of the Study:
- To summarize the current understanding of retinopathy of prematurity.
- To highlight the importance of early detection and established treatments for ROP.
Main Methods:
- Review of existing literature on retinopathy of prematurity.
- Analysis of risk factors, pathology, and current management strategies.
Main Results:
- ROP is characterized by abnormal retinal blood vessel development.
- Hypoxia is a major driver of pathological changes in ROP.
- Established treatments include laser therapy for the peripheral retina.
Conclusions:
- Early screening is essential for timely diagnosis of ROP.
- Prompt intervention can mitigate the risk of severe visual impairment and blindness in affected infants.
Abstract:
Retinopathy of prematurity is a proliferative retinal disorder diagnosed exclusively in prematurely born infants. In retinopathy of prematurity, growth of the retinal vasculature is disturbed, leading to hypoxia-induced pathological changes typical of retinopathy of prematurity, in the worst case resulting in retinal detachment. The most typical risk factors predisposing to the disease include hyperoxemia, low levels of insulin-like growth factor 1 (IGF-I), and low birth weight in relation to weeks of pregnancy. Laser therapy of peripheral retina is the currently established form of treatment. Screening is applied in order to recognize the pathological changes in retinopathy of prematurity early enough.
